In hepatocellular carcinoma, FGF8 subfamily members, including FGF8, FGF17 and FGF18, were upregulated to facilitate cell survival and angiogenesis via activating ERK [21]. This evidence concerns the gene FGF8 and hepatocellular carcinoma.